Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Total body irradiation (TBI)-based-conditioning before allogeneic hematopoietic stem cell transplantation (allo-HSCT) is standard of care in patients with acute myeloid leukemia (AML) but can cause long-term morbidity. Data on the impact of chronic Graft-versus-host disease (cGvHD) on cognitive function (CF) and quality of life (QoL) of long-term transplant survivors are sparse.
Methods: We analyzed patient-reported outcomes focusing on progression-free AML patients and 1st allo-HSCT applying a standardized TBI-technique with an average dose rate of 4 cGy/min to the total body and lung shielding in case of doses > 8 Gy. Instruments included the Functional Assessment of Cancer Therapy-Bone marrow transplant (FACT-BMT, version 4), the FACT-Cognition Function (FACT-Cog, version 3) and the Patient Health Questionaire-4 (PHQ-4). We put focus on the impact of cGvHD and compared the results to normative data derived from the general population.
Results: Out of 41 eligible patients contacted, 32 (78.0%) patients with a medium follow-up of 154 months (Interquartile range 113, 191 months) participated in the study. Eleven patients (34.4%) had active cGvHD, 11 (34.4%) resolved cGvHD and 10 (31.3%) never had cGvHD. Patients with active cGvHD had poorer FACT-BMT, FACT-Cog and higher PHQ-4 scores compared to patients with resolved cGvHD or who never had cGvHD. Outcomes were similar in patients with resolved cGvHD and those who never had cGvHD. Patients with active cGvHD had similar FACT-Cog, but lower FACT-BMT in comparison to normative data. However, the overall patient sample had similar FACT-BMT and FACT-Cog in comparison to normative data.
Conclusion: Our data indicate that CF of long-term survivors upon TBI-based allo-HSCT is not impaired, even in the presence of active cGvHD. However, active cGvHD has a negative impact on QoL. Trial registration The local Ethics Board of the University of Regensburg approved this study (Number 20-1810_1-101).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706937 | PMC |
| http://dx.doi.org/10.1186/s13014-022-02161-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comprehensive analysis of serum immune complexes identifies chronic graft-versus-host disease-associated antigenic molecules: A study by the Nagasaki transplant group.
Hum Immunol
August 2025
Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, Nagasaki University Graduate School of Biomedical Science, Nagasaki, Japan; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan; Department of Hematology, Atomic Bomb Disease and Hibakusha Medicine Unit, A
Chronic graft-versus-host disease (cGVHD) is an alloimmune disease characterized by inflammation, immune dysregulation, and pathogenic fibrosis after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Donor-derived B cells have a significant role of cGVHD development; however, the proteins targeted by B cell-mediated cGVHD remain unclear. To identify cGVHD-associated antigens, we investigated immune complexes (ICs) in the serum of patients who underwent allo-HSCT.
View Article and Find Full Text PDFThe KIR/HLA class I co-expression and transplantation outcomes after HSCT/BMT from HLA-matched sibling donors.
Transpl Immunol
September 2025
Department of Medical Immunology, Medical University of Gdańsk, Gdańsk, Poland.
Background: Natural killer (NK) cells express killer immunoglobulin-like receptors (KIRs), which regulate their functions. Self-human leukocyte antigens (HLA) class I molecules act as inhibitory molecules for KIRs, blocking the killing activity of NK cells. Since normal NK activity may affect the outcomes of hematopoietic stem cell transplantation (HSCT) or bone marrow transplantation (BMT) from their HLA-matched sibling donors, we investigated the interaction between KIRs and class I HLA presented on NK cells.
View Article and Find Full Text PDFDecreased HLA-DR+CD3+ T cells three months after allogeneic stem cell transplantation predict severe chronic GvHD and transplant-related mortality.
J Leukoc Biol
August 2025
Department of Internal Medicine V, Medical University of Innsbruck, Anichstraße 35, 6020 Innsbruck, Tyrol, Austria.
Chronic graft vs host disease (cGvHD) is a major late determinant of transplant related mortality (TRM) after allogeneic hematopoietic stem cell transplantation (HSCT). We investigated the predictive value of peripheral blood activated HLA-DR+CD3+ T cells as a novel biomarker. In total, 107 patients were included in this retrospective analysis.
View Article and Find Full Text PDFLip Verrucous Tumor in a Male With Chronic Graft-Versus-Host Disease.
Cureus
May 2025
Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, JPN.
Verruciform xanthoma (VX) is a rare benign tumor that usually occurs in the oral area or the urogenital region. Although VX sometimes arises in the oral space, VX on the lip is rare. The ratio of oral VX in chronic graft-versus-host disease (cGVHD) patients might be higher than that of the general population, and the frequency of lip cases may also be higher in cGVHD patients.
View Article and Find Full Text PDFDietary Micronutrient Intake in Long-Term Survivors of Pediatric Hematopoietic Stem Cell Transplantation.
Nutrients
May 2025
Department of Pediatrics and Adolescent Medicine, Copenhagen University Hospital-Rigshospitalet, 2100 Copenhagen, Denmark.
Background: Survivors of hematopoietic stem cell transplantation (HSCT) during childhood face significant late effects. This study aimed to map the dietary micronutrient intake of long-term survivors of pediatric HSCT and explore its associations with transplant outcomes, body composition, and physical capacity.
Methods: We included 85 long-term survivors of HSCT (median age 30 years) The median time since HSCT was 19.